Remdesivir Use Growing Globally in COVID-19 Patients
Yet, most physicians believe it is only moderately effective, better used earlier than official guidelines recommend
VA Slashes Use of Hydroxychloroquine to Treat COVID-19 Patients
Prescribing reduced to just three prescriptions in the last week as new research highlights possible dangers
Deferment of Elective Surgeries Due to COVID-19 Will Have Lasting Impact
Cumulative backlog includes more than 1 million surgeries at two years after end of elective surgery deferment
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Improving Glycemic Control May Also Aid COVID-19 Outcomes
Insulin infusion may reduce risk for severe disease in those with hyperglycemia and COVID-19
9.5 Percent Uninsured in U.S. From January Through June 2019
Overall, 13.7 percent of adults aged 18 to 64, 4.4 percent of children aged 0 to 17 were uninsured
Links Found Between Leaders of Medical Associations, Industry
Most leaders have ties to industry; considerable variation seen among 10 medical associations in U.S.
CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine
Risk increased for prolonged QT and/or ventricular tachycardia, including torsades de pointes
Parents Facing Higher Levels of Stress During Pandemic
Pandemic-related stress also disproportionately impacting communities of color
CDC: Coronavirus Antibody Tests Still Not Accurate Enough
Too little is known about what the presence of antibodies means in terms of future immunity
